Microbix Biosystems Inc (id:13799 MBX)
0.300 CAD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 2:32:18 PM)
Exchange closed, opens in 1 day 18 hours
About Microbix Biosystems Inc
Market Capitalization 43.75M
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
| Headquarters (address) |
265 Watline Avenue Mississauga L4Z 1P3 ON Canada |
| Phone | 905 361 8910 |
| Website | https://www.microbix.com |
| Employees | 0 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | MBX |
| Exchange | Toronto Stock Exchange |
| Currency | CAD |
| 52 week range | 0.280 - 0.450 |
| Market Capitalization | 43.75M |
| Dividend yield forward | 366.67 % |
| Dividend yield forward Canada (ID:82, base:386) | 5.73 % |
| P/E trailing | 8.00 |
| P/E forward | 16.00 |
| Price/Sale | 1.87 |
| Price/Book | 1.56 |
| Beta | 0.343 |
| EPS | 0.040 |
| EPS Canada (ID:82, base:722) | 1.84 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Microbix Biosystems Inc has raised their dividend 366.67 years in a row. This is below the 41500.772000 year average in the 'Biotechnology' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Microbix Biosystems Inc has raised their dividend 366.67 years in a row. This is below the 41500.772000 year average in the 'Biotechnology' industry